Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine Fumarate and Engineered Sound for Age-Related Central Auditory Processing Disorder
NCT07304024Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Mar 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clemastine in Central Auditory Processing Disorder (CAPD), sponsored by University of Colorado Denver. Started Mar 2025; status: recruiting.
02
Drugs
clemastine
03
Conditions
Central Auditory Processing Disorder (CAPD)
Beyond the preview
Go deeper on NCT07304024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304024.